PharmaShots | Incisive News in 3 Shots

Subscribe Now

Mineralys Therapeutics

Mineralys Therapeutics Reports P-II (Target-HTN) Trial Results of MLS-101 for Uncontrolled and Resistant Hypertension

Mineralys Therapeutics Reports P-II (Target-HTN) Trial Results of MLS-101 for Uncontrolled and Resistant Hypertension

November 17, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us